Below you'll find a list of all posts that have been tagged as “Tofacitinib”
In its July 27 print edition, Time magazine ran a full-page color ad for smokeless tobacco. But what really got our attention were all the drug ads, which continue week after week, and presumably keep the faltering publication alive. The biggest ad, an inside-front-cover three-page spread, was for Xeljanz (tofacitinib citrate), which is aimed at people with rheumatoid arthritis. As …
A diagnosis of cancer is devastating. But cancer sufferers who have followed medical provider advice to undergo treatment with so-called cancer-fighting drugs may have unknowingly been exposed to the additional risk of stroke or other life-threatening medical event. Why is this happening? The danger is due to tainted cancer medication in the form of sterile injectable drugs that the manufacturer began …
